Clinical Trial Update: Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of tirzepatide versus placebo or lisdexamfetamine dimesylate for binge-eating disorder; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder
• Obesity

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: Johns Hopkins University | Conditions: Obesity and Overweight, Binge Eating Disorder | Phase 2 | Status: RECRUITING